Based on ratings from 17 stock analysts, the Acadia Healthcare Co Inc stock price is expected to increase by 63.11% in 12 months. This is calculated by using the average 12-month stock price forecast for Acadia Healthcare Co Inc. The lowest target is $45 and the highest is $94. Please note analyst price targets are not guaranteed and could be missed completely.
About 17 Wall Street analysts have assignedACHC 10 buy ratings, 7 hold ratings, and 0 sell ratings. This means that analysts expect Acadia Healthcare Co Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ACHC. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ACHC.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Matthew Gillmor Keybanc | Sector Weight | Initiates | Oct 11, 2024 | |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Oct 4, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Oct 1, 2024 |
Andrew Mok Barclays | Overweight | $76 | Maintains | Sep 30, 2024 |
Ben Hendrix RBC Capital | Outperform | $94 | Reiterates | Sep 20, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 20, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 19, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 2, 2024 |
Pito Chickering Deutsche Bank | Hold | $75 | Maintains | Aug 2, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Aug 1, 2024 |
Andrew Mok Barclays | Overweight | $83 | Maintains | Aug 1, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 10, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 9, 2024 |
Sarah James Cantor Fitzgerald | Neutral | $90 | Reiterates | Jul 2, 2024 |
Ben Hendrix RBC Capital | Outperform | $94 | Reiterates | May 22, 2024 |
Gary Taylor TD Cowen | Buy | $91 | Maintains | May 17, 2024 |
Andrew Mok Barclays | Overweight | $89 | Maintains | May 15, 2024 |
Ann Hynes Mizuho | Neutral | $70 | Maintains | May 3, 2024 |
Andrew Mok Barclays | Overweight | $91 | Maintains | May 2, 2024 |
Kevin Fischbeck B of A Securities | Buy | $90 | Maintains | May 2, 2024 |
When did it IPO
1994
Staff Count
17,000
Country
United States
Sector/Industry
Healthcare/Medical Care Facilities
CEO
Mr. Christopher Howal Hunter
Market Cap
$3.91B
In 2023, ACHC generated $2.93B in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that ACHC's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - A class action lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ: ACHC) and some of its officers, as announced by Bronstein, Gewirtz & Grossman, LLC.
Why It Matters - A class action lawsuit against Acadia Healthcare could lead to financial liabilities and reputational damage, potentially impacting stock performance and investor confidence.
Summary - Investors in Acadia Healthcare Company (NasdaqGS: ACHC) who purchased securities from Feb 28, 2020, to Oct 18, 2024, have until Dec 16, 2024, to file lead plaintiff applications in a class action lawsuit.
Why It Matters - The class action lawsuit against Acadia Healthcare may impact investor sentiment and stock price, especially for those who purchased shares during the specified period.
Summary - Acadia Healthcare Company, Inc. (NASDAQ: ACHC) faces a class action lawsuit. Investors who purchased shares between Feb 28, 2020, and Sept 26, 2024, can apply to be lead plaintiff by Dec 16, 2024.
Why It Matters - The announcement of a class action lawsuit against Acadia Healthcare could lead to increased volatility in its stock price, impacting investor sentiment and potential returns.
Summary - A class action lawsuit has been filed against Acadia Healthcare (NASDAQ: ACHC) for alleged federal securities law violations, affecting investors from February 28, 2020, to October 18, 2024.
Why It Matters - A class action lawsuit against Acadia Healthcare for alleged securities law violations could impact stock performance, investor confidence, and potential financial liabilities for the company.
Summary - A class action lawsuit has been filed against Acadia Healthcare (NASDAQ: ACHC) for alleged federal securities law violations, covering investors from February 28, 2020, to October 18, 2024.
Why It Matters - A class action lawsuit against Acadia Healthcare may lead to financial liabilities and regulatory scrutiny, potentially impacting stock performance and investor confidence.
Summary - A class action lawsuit has been filed against Acadia Healthcare Company, Inc. (NASDAQ: ACHC). Investors can contact Pomerantz LLP for more information.
Why It Matters - A class action lawsuit against Acadia Healthcare may signal potential legal and financial risks, impacting stock performance and investor sentiment.